Search Results
Dec 12, 2025, 09:18 ET AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
proprietary Med-Oligo™ ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining efficient targeted delivery conjugation technologies, the modular Med-Oligo™ Platform empowers ASO therapeutics to treat a broad
More news about: AusperBio Therapeutics Inc.
Dec 12, 2025, 08:35 ET Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy
gene, the largest in the human body, contains 79 exons. Current disease-modifying therapeutic approaches for DMD include antisense oligonucleotides (ASO) mediated exon skipping, gene therapy, and gene editing, with exon skipping being the most common strategy. However, these treatments have significant
More news about: Ractigen Therapeutics
Dec 05, 2025, 09:05 ET Academy Sports + Outdoors Announces Quarterly Cash Dividend
Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (Nasdaq: ASO) announced today that on December 4, 2025, its Board of Directors declared a quarterly cash dividend with respect to the fiscal quarter ended November
More news about: Academy Sports + Outdoors
Dec 02, 2025, 09:05 ET Academy Sports + Outdoors Appoints Three to its Board of Directors
Texas, Dec. 2, 2025 /PRNewswire/ -- Academy Sports and Outdoors, Inc. ("Academy" or the "Company") (Nasdaq: ASO) today announced that Michael Dastugue, Shannon Hennessy, and Clay Johnson have been appointed to its Board of Directors (the "Board"), and Mr. Dastugue
More news about: Academy Sports + Outdoors
Nov 27, 2025, 10:01 ET Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare
Commercial scaling of gene therapies for hemoglobinopathies, neuromuscular disorders, and inherited retinal diseasesRise of mRNA & ASO precision medicines targeting ultra-rare genetic variantsDisease-modifying therapies for neurological & metabolic conditionsGlobal
More news about: DataM Intelligence 4 Market Research LLP
Nov 25, 2025, 08:55 ET Academy Sports + Outdoors Announces Third Quarter Fiscal 2025 Results Conference Call
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, plans to release its third quarter fiscal 2025 financial results before the market
More news about: Academy Sports + Outdoors
Nov 20, 2025, 07:00 ET SciNeuro Pharmaceuticals to Accelerate Novel LRRK2 Therapeutic (SNP614) Development with an Award from The Michael J. Fox Foundation
announced it has received a research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to advance the company's novel, LRRK2-targeted ASO program (SNP614) toward IND. In tandem, SciNeuro has joined MJFF's LRRK2 Investigative Therapeutics Exchange (LITE) program. This
More news about: SciNeuro Pharmaceuticals
Nov 19, 2025, 10:13 ET Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
diseases, today announced the nomination of APRTX-001 as its development candidate. APRTX-001 is a CD33-targeting antisense oligonucleotide (ASO) designed for the treatment of Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS), with strong potential for indication expansion
More news about: Aperture Therapeutics
Nov 18, 2025, 09:05 ET Academy Sports + Outdoors Opens Five New Stores in Q4, Taking New Store Total to 24 in Fiscal 2025
Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce it has opened five new locations in Q4 2025 in
More news about: Academy Sports + Outdoors
Nov 17, 2025, 11:58 ET EICMA 2025: una edición que bate récords
una buena causa. La exposición se enriqueció aún más con la muestra "Reinas del Desierto", creada en colaboración con ASO – Amaury Sport Organisation: un homenaje a la historia y la leyenda del Rally Dakar, con 31 motocicletas originales expuestas por primera vez en Italia,
More news about: EICMA
Nov 17, 2025, 11:24 ET EICMA 2025 : UNE ÉDITION RECORD, ALLIANT PASSION, AFFAIRES, NOUVEAUX CONTENUS ET NOUVELLES FAÇONS DE SE RENDRE AU SALON
automobile pour une bonne cause. L'exposition a été enrichie par l'exposition « Desert Queens », créée en collaboration avec ASO - Amaury Sport Organisation : un hommage à l'histoire et à la légende du Rallye Dakar, avec 31 motos originales exposées pour la première fois en Italie,
More news about: EICMA
Nov 17, 2025, 11:18 ET EICMA 2025: EINE REKORDVERDÄCHTIGE AUSGABE, DIE LEIDENSCHAFT, GESCHÄFT, NEUE INHALTE UND NEUE MÖGLICHKEITEN, DIE MESSE ZU BESUCHEN, VEREINT
guten Zweck trafen. Die Ausstellung wurde durch die Ausstellung „Desert Queens" bereichert, die in Zusammenarbeit mit der ASO - Amaury Sport Organisation entstand: eine Hommage an die Geschichte und die Legende der Rallye Dakar, mit 31 Originalmotorrädern, die zum ersten Mal
More news about: EICMA
Nov 17, 2025, 09:08 ET EICMA 2025: A RECORD-BREAKING EDITION, COMBINING PASSION, BUSINESS, NEW CONTENT, AND NEW WAYS TO GET TO THE SHOW
for a good cause. The exhibition was further enriched by the "Desert Queens" exhibition, created in collaboration with ASO – Amaury Sport Organisation: a tribute to the history and legend of the Dakar Rally, with 31 original motorcycles on display for the first time in Italy,
More news about: EICMA
Nov 17, 2025, 09:05 ET EICMA 2025: A RECORD-BREAKING EDITION, COMBINING PASSION, BUSINESS, NEW CONTENT, AND NEW WAYS TO GET TO THE SHOW
for a good cause. The exhibition was further enriched by the "Desert Queens" exhibition, created in collaboration with ASO – Amaury Sport Organisation: a tribute to the history and legend of the Dakar Rally, with 31 original motorcycles on display for the first time in Italy,
More news about: EICMA
Nov 13, 2025, 08:00 ET LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner
is a next-generation BBB-penetrating delivery platform capable of transporting diverse therapeutic modalities—including antisense oligonucleotides (ASO), siRNA, and small molecules—directly into the brain. Compared to existing BBB shuttles, ExoPN-101 demonstrates superior brain delivery efficiency and
More news about: LISCure BioSciences
Nov 08, 2025, 08:30 ET AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
Med-OligoTM ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining efficient targeted delivery conjugation technologies, the modular Med-OligoTM Platform empowers ASO therapeutics to treat
More news about: AusperBio Therapeutics Inc.
Nov 06, 2025, 16:10 ET Evolent Announces Third Quarter 2025 Results
Performance Suite Lives on Platform are calculated by summing monthly members covered for specialty care services for contracts not under ASO arrangements, plus members managed by Complex Care in capitation arrangements and divided by the number of months in the period. Specialty Technology
More news about: Evolent Health, Inc.
Nov 06, 2025, 14:00 ET Academy Sports + Outdoors Unwraps this Holiday Season's Top Gifts Delivering Legendary Value and Undefeatable Prices
Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO) is making it easier than ever for families to create lasting memories without breaking the bank. With unbeatable deals on top brands, a wide assortment
More news about: Academy Sports + Outdoors
Nov 04, 2025, 09:00 ET Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
https://abbo.tt/ASO_ISI. For U.S. Important Safety Information about the Masters mechanical heart valve, visit
More news about: Abbott
Oct 21, 2025, 08:23 ET Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers
expression and significant tumor-volume reduction by Day 8 in systemic mastocytosis and GIST models. HT-KIT, a precision antisense oligonucleotide (ASO) targeting KIT mRNA, also completed GLP-validated bioanalytical methods supporting IND-enabling studies; Japan Patent No. 7677628 extends platform protection
More news about: Hoth Therapeutics, Inc.
Oct 09, 2025, 10:06 ET It's Croctober at Academy Sports + Outdoors: Celebrate With Your Favorite Styles During Crocs Week
Nasdaq: ASO) is stepping out in style all month long in celebration of Croctober. Whether you're a fan of the
More news about: Academy Sports + Outdoors
Oct 07, 2025, 11:20 ET Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes
reimbursement frameworks for rare disease drugs. Recent update (2025): Biogen received FDA approval for a next-generation ASO targeting ALS progression. Japan Japan's
More news about: DataM Intelligence 4 Market Research LLP
Oct 07, 2025, 11:00 ET Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care
one-time treatments will revolutionize patient outcomes. RNA-based Leadership – mRNA, RNAi, and ASO platforms will expand across neuromuscular and metabolic rare diseases. AI-enabled Precision Medicine –
More news about: DataM Intelligence 4 Market Research LLP
Oct 07, 2025, 10:06 ET Academy Sports + Outdoors Celebrates "Brooks Month" with Exclusive Launch of Hero Collection
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is celebrating "Brooks Month" all October-long. Adding to the lineup of Brooks
More news about: Academy Sports + Outdoors
Oct 02, 2025, 08:55 ET Academy Sports + Outdoors Continues Pursuit of Becoming the Best Sports + Outdoors Retailer in the Country
Nasdaq: ASO), is well on its way after going public in 2020. The Company's growth strategy is rooted in opening new stores, investing in the e-commerce experience
More news about: Academy Sports + Outdoors